Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Stimulating effect of external Myo-inositol on the expression of mutant forms of aquaporin 2.
Lussier Y
,
Bissonnette P
,
Bichet DG
,
Lapointe JY
.
???displayArticle.abstract???
Myo-inositol (MI; hexahydroxycyclohexane, C(6)H(6)O(12)) is a small neutral molecule used as a compatible osmolyte in the kidney medulla. At high concentrations, MI appears to act as a chemical chaperone and was shown to promote plasma membrane expression of the impaired cystic fibrosis chloride channel (Delta508-CFTR). In the present study, we measured whether MI could increase expression of two human aquaporin 2 (AQP2) mutants which were recently identified as causing nephrogenic diabetes insipidus (NDI). Both proteins (D150E and G196D) were expressed in Xenopus laevis oocytes, but only D150E displayed an increase in oocyte water permeability (P (f)). Adding 5 mM MI to the bathing solution for 24 h produced a 50% increase in the D150E-associated P (f), while it had no effect on noninjected oocytes or on oocytes expressing wt-AQP2 or G196D. Western blots performed on purified plasma membrane preparations confirmed that MI increased the amount of D150E present at the plasma membrane, while G196D was always undetectable. X. laevis oocytes are remarkably impermeable to MI, and the effect of MI on D150E expression does not require the presence of intracellular MI. The effect of external MI was dose-dependent (K (0.5) was 130 microM) and specific with respect to other forms of inositols. Further studies on a second group of AQP2 mutants causing NDI showed that K228E activity was similarly stimulated by MI, while V71M, A70D and S256L were not. It is concluded that physiological concentrations of extracellular MI can stimulate the expression of a specific subgroup of AQP2 mutants.
Bagnasco,
Predominant osmotically active organic solutes in rat and rabbit renal medullas.
1986, Pubmed
Bagnasco,
Predominant osmotically active organic solutes in rat and rabbit renal medullas.
1986,
Pubmed
Bissonnette,
Effects of hyperosmolarity on the Na+ -myo-inositol cotransporter SMIT2 stably transfected in the Madin-Darby canine kidney cell line.
2008,
Pubmed
Bissonnette,
Functional expression of tagged human Na+-glucose cotransporter in Xenopus laevis oocytes.
1999,
Pubmed
,
Xenbase
Bonifacino,
Ubiquitin and the control of protein fate in the secretory and endocytic pathways.
1998,
Pubmed
Cheong,
Two novel mutations in the aquaporin 2 gene in a girl with congenital nephrogenic diabetes insipidus.
2005,
Pubmed
Coady,
Identification of a novel Na+/myo-inositol cotransporter.
2002,
Pubmed
,
Xenbase
Duquette,
Local osmotic gradients drive the water flux associated with Na(+)/glucose cotransport.
2001,
Pubmed
,
Xenbase
Fisher,
Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance.
2002,
Pubmed
Guyon,
Characterization of D150E and G196D aquaporin-2 mutations responsible for nephrogenic diabetes insipidus: importance of a mild phenotype.
2009,
Pubmed
,
Xenbase
Holub,
Metabolism and function of myo-inositol and inositol phospholipids.
1986,
Pubmed
Howard,
Mammalian osmolytes and S-nitrosoglutathione promote Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) protein maturation and function.
2003,
Pubmed
Lapointe,
Controversy regarding the secondary active water transport hypothesis.
2002,
Pubmed
,
Xenbase
Leduc-Nadeau,
Elaboration of a novel technique for purification of plasma membranes from Xenopus laevis oocytes.
2007,
Pubmed
,
Xenbase
Loo,
Cotransport of water by the Na+/glucose cotransporter.
1996,
Pubmed
,
Xenbase
Marr,
Cell-biologic and functional analyses of five new Aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus.
2002,
Pubmed
,
Xenbase
McDill,
Congenital progressive hydronephrosis (cph) is caused by an S256L mutation in aquaporin-2 that affects its phosphorylation and apical membrane accumulation.
2006,
Pubmed
McLaurin,
Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity.
2000,
Pubmed
Mishra,
Chemical chaperone-mediated protein folding: stabilization of P22 tailspike folding intermediates by glycerol.
2007,
Pubmed
Novak,
Differentiated human NT2-N neurons possess a high intracellular content of myo-inositol.
1999,
Pubmed
Ozcan,
Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.
2006,
Pubmed
Schröder,
The mammalian unfolded protein response.
2005,
Pubmed
Tamarappoo,
Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones.
1998,
Pubmed
,
Xenbase
Welch,
Influence of molecular and chemical chaperones on protein folding.
1996,
Pubmed
Zhang,
Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator.
2003,
Pubmed